DongKook Pharmaceutical Co., Ltd. (KOSDAQ: 086450)
South Korea
· Delayed Price · Currency is KRW
18,030
+1,560 (9.47%)
Nov 15, 2024, 9:00 AM KST
DongKook Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 772,963 | 710,431 | 729,658 | 958,073 | 1,285,488 | 783,159 | |
Market Cap Growth | 30.46% | -2.64% | -23.84% | -25.47% | 64.14% | 53.89% | |
Enterprise Value | 841,382 | 751,610 | 743,265 | 932,778 | 1,201,020 | 718,740 | |
Last Close Price | 17580.00 | 16160.00 | 16414.41 | 21331.34 | 28392.71 | 17192.17 | |
PE Ratio | 14.43 | 15.32 | 13.88 | 18.94 | 22.70 | 13.66 | |
Forward PE | 11.71 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | |
PS Ratio | 1.01 | 0.97 | 1.10 | 1.61 | 2.30 | 1.62 | |
PB Ratio | 1.38 | 1.18 | 1.31 | 1.90 | 2.82 | 2.03 | |
P/TBV Ratio | 1.49 | 1.33 | 1.48 | 2.14 | 3.18 | 2.19 | |
P/FCF Ratio | 88.79 | 93.28 | - | - | 65.92 | 17.66 | |
P/OCF Ratio | 18.49 | 17.00 | 17.84 | 21.46 | 21.75 | 11.27 | |
EV/Sales Ratio | 1.10 | 1.03 | 1.12 | 1.57 | 2.15 | 1.49 | |
EV/EBITDA Ratio | 8.55 | 8.54 | 8.02 | 11.58 | 12.29 | 8.73 | |
EV/EBIT Ratio | 11.38 | 11.24 | 10.11 | 14.75 | 14.54 | 10.46 | |
EV/FCF Ratio | 96.65 | 98.69 | - | - | 61.59 | 16.21 | |
Debt / Equity Ratio | 0.12 | 0.13 | 0.12 | 0.19 | 0.15 | 0.16 | |
Debt / EBITDA Ratio | 0.77 | 0.87 | 0.72 | 1.22 | 0.70 | 0.73 | |
Debt / FCF Ratio | 8.71 | 10.07 | - | - | 3.51 | 1.36 | |
Asset Turnover | 0.90 | 0.91 | 0.87 | 0.84 | 0.93 | 0.94 | |
Inventory Turnover | 2.33 | 2.48 | 2.53 | 2.69 | 3.17 | 3.08 | |
Quick Ratio | 1.27 | 1.34 | 1.49 | 1.40 | 2.15 | 2.47 | |
Current Ratio | 2.00 | 2.06 | 2.22 | 1.91 | 2.75 | 3.08 | |
Return on Equity (ROE) | 9.10% | 8.42% | 10.33% | 11.03% | 13.76% | 16.47% | |
Return on Assets (ROA) | 5.46% | 5.20% | 6.05% | 5.59% | 8.55% | 8.38% | |
Return on Capital (ROIC) | 6.86% | 6.41% | 7.51% | 7.02% | 10.64% | 10.32% | |
Earnings Yield | 6.93% | 6.64% | 7.25% | 5.25% | 4.35% | 7.19% | |
FCF Yield | 1.13% | 1.07% | -0.96% | -0.66% | 1.52% | 5.66% | |
Dividend Yield | 1.00% | 1.11% | - | - | - | - | |
Payout Ratio | 15.26% | 17.07% | 15.22% | 15.99% | 12.79% | 8.26% | |
Buyback Yield / Dilution | -0.02% | -0.02% | -0.01% | - | - | -0.94% | |
Total Shareholder Return | 0.98% | 1.10% | -0.01% | - | - | -0.94% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.